Drug class
Topical antimitotic lignan; tubulin-binding microtubule inhibitor
Mechanism of action
Binds tubulin and inhibits its polymerisation, preventing microtubule assembly and arresting dividing cells in metaphase. Local cytotoxicity produces necrosis of HPV-infected wart tissue.
General use cases
- Topical treatment of external anogenital warts, including genital and perianal warts, with authorised cream or solution formulations.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
